Rheumatoid arthritis patient group

Includes a description of RA and incidence and prevalence of RA. RA is a serious and often disabling condition that can cause chronic pain, permanent joint damage, and loss of joint function. Some research indicates that, instead of a single condition, rheumatoid arthritis may in fact be rheumatoid arthritis patient group group of different diseases that have several common features. According to the Arthritis Foundation, RA is the second most common type of arthritis.

3 million people in the United States, and about 70 percent of patients who have the disease are women. Rheumatoid arthritis usually develops between the ages of 30 and 50, but it can occur at any age. In women who are of childbearing age, RA often improves during pregnancy, but symptoms may increase in severity after the patient gives birth. Copyright 2017 Remedy Health Media, LLC. The content on this website is provided for educational purposes only. Use of this site is subject to the policies and terms of use.

This website is certified by Health On the Net Foundation. Two main types of rheumatoid arthritis are seropositive and seronegative. Researchers aim to further identify subtypes to provide personalized treatment. Different symptoms and progression rates turn up in different patients.

Though it isn’t totally clear what drives these differences, researchers do know that it largely depends on genetics. Further and further, researchers are finding ways to classify the types and sub-types of rheumatoid arthritis by the actual symptoms patients experience, in addition to other factors. Because of the progressive nature of the disease as well as its tendency to evolve over time, it may be that patients are told they have multiple types or subtypes over the course of their lives. This will help provide more personalized therapy and medical treatment options.

As of now, there is a primary way of defining the type of rheumatoid arthritis a patient has. This difference can determine treatment options. These are the antibodies that attack the body and produce the symptoms of rheumatoid arthritis. CCPs, meaning it is a reliable indicator for diagnosis. The presence of these antibodies can be detected as early as 5 to 10 years before clinical rheumatoid arthritis symptoms appear. It’s still possible for patients to develop rheumatoid arthritis without the presence of antibodies in their blood. This is referred to as seronegative type rheumatoid arthritis.